Skip to main content

Table 3 Analysis of the secondary outcomes at baseline and after three month follow-up

From: A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia

Variable

Lifestyle wellness program (n=60)

Standard care (n=66)

p

Baseline

3-month

Baseline

3-month

ILSS

0.76 (0.1)

0.76 (0.1)

0.76 (0.1)

0.76 (0.09)

0.595

WHOQoL

     

Physical

60.2 (15.9)

58.7 (15.4)

59.0 (16.6)

60.5 (17.4)

0.270

Psychological

54.9 (18.0)

58.4 (18.9)

58.4 (16.8)

61.1 (19.3)

0.736

Social relations

53.9 (23.4)

56.9 (22.2)

53.0 (25.5)

56.9 (24.5)

0.803

Environmental

54.8 (15.6)

57.1 (14.4)

55.8 (14.2)

56.5 (16.2)

0.489

Rosenberg self esteem

12.1 (4.3)

11.8 (4.8)

12.3 (5.0)

12.2 (5.0)

0.811

Fagerström tolerance questionnaire

6.3 (2.1)

6.4 (2.7)

6.3 (2.7)

6.3 (2.7)

0.331

DINE

     

Fibers

40.1 (20.8)

44.4 (17.9)

42.6 (18.2)

42.4 (17.1)

0.211

Fat

32.0 (13.9)

30.2 (12.3)

34.7 (14.9)

37.2 (14.7)

0.126

Unsatured fat

9.8 (1.9)

10.1 (1.6)

10.0 (1.7)

10.3 (1.2)

0.944

IPAQ

     

Walking

843.4 (1113.5)

1390.8 (2078.7)

670.6 (903.5)

1049.2 (1191.4)

0.410

Moderate activity

1006.7 (2021.8)

910.2 (1618.4)

1007.8 (2002.2)

1446.7 (3701.7)

0.503

Vigorous activity

750.6 (1677.8)

778.2 (1857.1)

559.5 (1626.2)

530.9 (1202.4)

0.873

Total

2591.7 (3258.4)

3116.6 (4234.1)

2314.4 (3167.9)

3088.5 (4787.2)

0.294